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Abstract
Background: A substantial number of patients do not benefit from first line psychological therapies for the
treatment of depression and anxiety. Currently, there are no clear predictors of treatment outcomes for these
patients. The PROMPT project aims to establish an infrastructure platform for the identification of factors that
predict outcomes following psychological treatment for depression and anxiety. Here we report on the first year of
recruitment and describe the characteristics of our sample to date.
Methods: One hundred and forty-seven patients awaiting treatment within an Improving Access to Psychological
Therapies (IAPT) service were recruited between February 2014 and February 2015 (representing 48 % of those
eligible). Baseline assessments were conducted to collect information on a variety of clinical, psychological and
social variables including a diagnostic interview using the Mini International Neuropsychiatric Interview (MINI).
Results: Our initial findings showed that over a third of our sample were not presenting to IAPT services for the
first time, and 63 % had been allocated to receive higher intensity IAPT treatments. Approximately half (46 %) were
taking prescribed psychotropic medication (most frequently antidepressants). Co-morbidity was common: 72 % of
the sample met criteria for 2 or more current MINI diagnoses. Our initial data also indicated that 16 % met criteria
for borderline personality disorder and 69 % were at high risk of personality disorder. Sixty-one percent scored
above the screening threshold for bipolarity. Over half of participants (55 %) reported experiencing at least one
stressful life event in the previous 12 months, whilst 67 % reported experiencing at least one form of childhood
trauma.
Conclusions: Our results to date highlight the complex nature of patients seen within an urban IAPT service, with
high rates of psychiatric comorbidity, personality disorder, bipolarity and childhood trauma. Whilst there are
significant challenges associated with researching IAPT populations, we have also confirmed the feasibility of
undertaking such research.
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Background
The Improving Access to Psychological Therapies (IAPT)
service was developed to provide psychological treatments
for people with depression and anxiety in order to address
both the high prevalence and burden of these disorders,
and the number of untreated individuals [1, 2]. The thera-
peutic approaches used by IAPT are those recommended
as first-line treatment for mild to moderate depression and
anxiety by the National Institute for Clinical Excellence [3].
IAPT services offer both individual and group therapy op-
tions including cognitive behavioural therapy (CBT) and
other NICE recommended talking therapies [4, 5]. The ser-
vice is organised to provide stepped care, whereby patients
are offered two levels of care (‘low intensity’ and ‘high in-
tensity’) depending on their severity of symptoms and/or
patient preference [6]. High intensity therapies include
CBT, counselling and interpersonal psychotherapy and low
intensity therapies include guided self-help, behavioural ac-
tivation, mindfulness groups and wellbeing workshops.
IAPT services use a standardised protocol and collect
symptomatic and functional outcome data session-by-
session. This provides an opportunity for researchers to
study outcome data on large populations of individuals with
common mental health disorders undergoing standardised,
evidence based psychological treatments.
IAPT services now receive almost 900,000 referrals a
year and more than half of those referred successfully
enter treatment [7]. Over its first 3 years, the IAPT
programme reported early successes, notably the treat-
ment of “the first million patients” [5]. Overall recovery
rates were 45 % in the last quarter of 2011/12, demon-
strating consistent improvement over the duration of the
programme [5]. Recovery rates are defined as moving
from caseness to non-caseness on self-rated measures of
low mood and anxiety. A score of 10 or more on the
Patient Health Questionnaire (PHQ-9) is used to indi-
cate caseness for depression and a score of 8 or more on
the Generalized Anxiety Disorder 7 (GAD-7) is used to
indicate caseness for anxiety [8, 9]. Whilst these recovery
rates are encouraging, they also indicate that approxi-
mately half of patients are not meeting standard defini-
tions of recovery at the end of their treatments.
Furthermore, it is likely that a substantial proportion of
those who do recover may go on to relapse in due
course. Our knowledge of predictors of treatment re-
sponse for depression and anxiety, both in terms of
psychological and pharmacological treatments, is lim-
ited. It is likely that depression and anxiety have many
underlying causes, across psychological, social, and bio-
logical domains, all of which may feasibly affect outcome
or choice of treatment. Only by studying large cohorts
of patients receiving treatments, will it be possible to
identify factors which predict positive or negative re-
sponse. Indeed, by furthering our understanding of this,
new treatment targets can be developed, and existing
treatments can be more effectively applied.
The predicting outcome following psychological therapy
in IAPT (PROMPT) project provides an infrastructure to
allow for the systematic collection of data geared towards
understanding the predictors of treatment outcomes. Fur-
thermore, through PROMPT we can identify subgroups of
participants who do not respond to existing treatments in
order to devise experimental studies for the identification
of new treatments (both psychological and pharmaco-
logical). To our knowledge, this is the first study to collect
systematically both clinical and biological data within an
IAPT population and we have previously published the
complete protocol for this project [6]. The main objective
of the PROMPT project is to identify factors that predict
response or lack of response to psychological treatment
delivered by IAPT services for depression and anxiety.
Here, we report on the sample from the first year of re-
cruitment. Our main aim in this report was to describe in
detail the demographic and clinical characteristics of the
sample recruited to date, including potential implications
for IAPT services and the representativeness of the study.
All biological samples will be analysed in relation to treat-
ment outcome and therefore are not available for report-
ing at this early stage.
Methods
Study design and participants
This project uses a naturalistic, observational design. All
patients are recruited from one South London IAPT service
– Southwark Psychological Therapies Service (SPTS). All
eligible patients referred (self-referral or via general practi-
tioner) to SPTS are initially asked to consent to be con-
tacted for research purposes as part of standard clinical
practice. Patients who consent for research contact are
identified via the IAPT electronic patient record system
(IAPTus). Identified patients are then approached by post,
telephone or email and asked to take part in the project
prior to starting their therapy. Inclusion criteria for this
project are any patients who are accepted by the IAPT ser-
vice for treatment and are able to give informed consent.
Patients are excluded if they are not sufficiently fluent in
English (as indicated on their electronic record by the re-
quirement of an interpreter). Written informed consent is
obtained from all participants after a complete explanation
of the study, a presentation of a participant information
sheet and an opportunity to ask questions. All data are col-
lected at a baseline research visit which takes place at the
NIHR/Wellcome Trust King’s Clinical Research Facility.
This visit involves a diagnostic interview carried out with
a trained researcher, completion of a range of question-
naires and collection of biological samples (blood and
hair). All participants included in this report were re-
cruited between February 2014 and February 2015. The
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project was approved by the Bromley NHS Research
Ethics Committee (Ref: 13/LO/1347).
Demographic and treatment factors
Date of birth and self-identified ethnicity was collected
from the participants’ electronic IAPT patient record.
Information regarding treatment such as the number of
previous IAPT episodes and whether or not the partici-
pant is due to receive high intensity or low intensity
IAPT therapy was also collected from these electronic
records. High intensity therapies include individual CBT,
counselling and interpersonal psychotherapy. Low inten-
sity therapies include guided self-help, behavioural activa-
tion, mindfulness groups and wellbeing workshops.
Additional demographic information was collected as part
of the questionnaire measures participants are administered
during the PROMPTassessment including: relationship sta-
tus, educational attainment, employment status, housing
status and household income.
Diagnoses & symptomatology
The Mini International Neuropsychiatric Interview
(MINI) was used to assess current and lifetime diagnoses
for all participants. The MINI is a structured interview
which assesses DSM diagnoses, and is rapid to adminis-
ter. The MINI covers the following diagnoses: major de-
pressive episode (including recurrent major depression
and major depression with melancholic features); dys-
thymia; suicidality; mania and hypomania; panic disorder;
social phobia; agoraphobia; obsessive compulsive disorder;
post-traumatic stress disorder; alcohol abuse; alcohol de-
pendence; substance abuse; substance dependence; psych-
otic disorders; mood disorder with psychotic features;
anorexia; bulimia; generalised anxiety disorder; and anti-
social personality disorder [10]. During the interview par-
ticipants were also administered the borderline personality
subsection of the Structured Clinical Interview for DSM-
IV Personality Disorders (SCID-II) and the Hypomania
Checklist (HCL-16) [11, 12]. The HCL-16 is a 16 item
measure where a score of ≥8 is used as a cut-off point sug-
gestive of some degree of bipolarity.
In addition to the diagnoses established by the MINI,
depression and anxiety symptoms were further assessed
using the Patient Health Questionnaire (PHQ-9) and the
Generalized Anxiety Disorder assessment (GAD-7) [8, 9].
Both of these measures are self-report and are routinely
collected as part of standard IAPT practice at every treat-
ment session which will allow us to compare pre- and
post-therapy scores. A score of ≥10 on the PHQ-9 is used
to indicate caseness. For use as a Generalized Anxiety
Disorder (GAD) screen, a score of ≥10 is also recom-
mended on the GAD-7. However, it also has satisfactory
(albeit lower) sensitivity and specificity for detecting other
anxiety disorders when a cut off of ≥8 is used and indeed
this is the cut-off used by IAPT services to indicate
caseness. The Standardised Assessment of Personality
Abbreviated Scale (SAPAS) was used to screen for person-
ality disorder [13]. This is an eight item measure where a
score of ≥3 is indicative of cases at high risk of personality
disorder.
Psychosocial stress
Stressful life events were assessed using the List of
Threatening Events Questionnaire [14]. This is a self-
report questionnaire examining the incidence of 12 cat-
egories of negative life events involving moderate or
long-term threats such as illness or injury, the death of a
close friend or relative, unemployment, financial loss
and loss of important relationships. Participants indicate
whether they have experienced such an event and the date
that it occurred. We focused specifically on life events
which took place in the 12 months prior to the baseline
interview in order to have an indication of recent stressors
prior to engaging in IAPT services. A dichotomised vari-
able was created to indicate: no life events experienced in
the previous 12 months, versus one or more life events ex-
perienced in the previous 12 months.
Traumatic events during childhood were assessed using
the Childhood Trauma Questionnaire [15]. This is a self-
report measure that assesses five domains of trauma
occurring prior to age 17. These are: emotional abuse,
physical abuse, sexual abuse, emotional neglect, and phys-
ical neglect. Each item is rated on a five point Likert scale
from “never true” to “very often true”, with scores for each
sub scale ranging from 5 to 25. The authors provide the
following severity indications: emotional abuse (5–8, none;
9–12, low; 13–15, moderate; ≥16 severe); physical abuse
(5–7, none; 8–9, low; 10–12, moderate; ≥13 severe); sexual
abuse (5, none; 6–7, low; 8–12, moderate; ≥13 severe);
emotional neglect (5–9, none; 10–14, low; 15–17, moder-
ate; ≥18 severe); and physical neglect (5–7, none; 8–9,
low; 10–12, moderate; ≥13 severe).
Data analyses
All data were analyzed using IBM SPSS statistical soft-
ware version 20. Continuous variables are presented as
mean ± SEM.
Results
Recruitment
One hundred and forty-seven patients were successfully
recruited during the first year of the PROMPT project.
Figure 1 illustrates the recruitment flow. We were unable
to make full contact with 50 % of the patients identified by
our searches. Participants were deemed to be uncontact-
able once all contact methods had been explored (letter in
the post, minimum of two phone call attempts and an
email). Once contact with potential participants had been
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established, their eligibility was re-assessed and those who
violated the protocol were excluded from participating.
Protocol violations included those who had already begun
their therapy at the point of contact or those who indi-
cated they would no longer be receiving therapy within
Southwark Psychological Therapies Service. As such, 306
patients were deemed to be eligible to participate in the
study and 48 % of these patients were successfully
recruited. The foremost reason for patients declining to
participate was due to not having time to be able to attend
the research interview prior to starting therapy.
Demographic and treatment factors
The demographic characteristics of the sample are pre-
sented in Table 1. Our sample was predominantly com-
prised of patients who were waiting to receive higher
intensity IAPT treatments (63 %) most often individual
CBT. For 38 % of the sample, this was not the first IAPT
episode and approximately half (46 %) were taking pre-
scribed psychotropic medication at the time of the inter-
view (most frequently antidepressants: 28 patients were
taking citalopram, 17 patients were taking sertraline, seven
patients were taking fluoxetine, five patients were taking
mirtazapine, four patients were taking amitriptyline and
three patients were taking paroxetine). Duration of current
illness was available in 85 participants and the median was
241 days.
Diagnoses and symptomatology
The MINI allows for the identification of both current
and lifetime diagnoses. Table 2 illustrates the preva-
lence of all MINI diagnoses in our sample. We specific-
ally investigated the current diagnoses as well as the
number of multiple diagnoses given; these are
presented in Figs. 2 and 3 respectively. Seventy-two
percent of the sample met criteria for 2 or more
current MINI diagnoses. Further to the MINI diagno-
ses, our initial data also indicates 16 % of the sample
met criteria for borderline personality disorder and
69 % scored above the cut-off (≥3) on the personality
disorder screen. Moreover, 61 % scored above the cut-
off (≥8) for hypomania on the HCL-16. Finally, the
mean depression and anxiety scores of the sample as
measured by the PHQ-9 and GAD-7 were 13.4 ± 0.6
and 12.0 ± 0.5 respectively. Seventy-two percent of the
sample scored above the cut-off (≥10) for depression
and 78 % scored above the cut-off (≥8) used by IAPT
services for anxiety. The complete breakdown of the
severity of PHQ-9 and GAD-7 scores are presented in
Table 3.
IAPTUs search for:
All wait listed patients with 
consent for research contact
875 patients
Contact made
417 patients
Unable to contact
458 patients
Protocol violations
111 patients
Eligible to participate
306 patients
Recruited
147 patients
Declined to participate
159 patients
Fig. 1 Recruitment flow
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Psychosocial stress
Firstly, we investigated the prevalence of stressful live
events in the previous 12 months in our sample. Fifty-five
percent of participants reported experiencing at least one
life event in the previous 12 months. We also investigated
the prevalence of childhood trauma. Just under a third
(29 %) of participants reported moderate or severe emo-
tional abuse, 16 % reported moderate or severe physical
abuse, 21 % reported moderate or severe sexual abuse,
31 % reported moderate or severe emotional neglect and
23 % reported moderate or severe physical neglect. Sixty-
seven percent of participants reported experiencing at
least one form of childhood trauma. The complete
Table 1 Socio-demographic characteristics of the sample
Age (years)
Mean ± SEM 40.3 ± 1.1
Range 18–77
Gender
Females 94 (64 %)
Males 53 (36 %)
Ethnicity
White British 90 (61 %)
White Other 32 (22 %)
Mixed 5 (3 %)
Black 6 (4 %)
Pakistani/Indian/Bangladeshi 4 (3 %)
Other 10 (7 %)
Education Levela
No Qualifications 15 (11 %)
GCSEs/O Levels/NVQ 22 (15 %)
A Levels/GNVQ 36 (25 %)
Higher degree 71 (49 %)
Employmenta
Full-time 60 (41 %)
Part-time 18 (13 %)
Student 15 (10 %)
Unemployed 29 (20 %)
Sick Leave/Homemaker 23 (16 %)
Relationship Statusa
Single 62 (44 %)
Steady relationship 34 (24 %)
Married 37 (26 %)
Separated/Divorced 7 (5 %)
Widowed 2 (1 %)
Housinga
Owned/Mortgaged 37 (26 %)
Rented private 41 (28 %)
Rented from local authority 52 (36 %)
Other 14 (10 %)
Household incomea
£0–£5,475 31 (22 %)
£5,476–£12,097 15 (11 %)
£12,098–£20,753 19 (13 %)
£20,754–£31,494 26 (18 %)
Above £31,495 52 (36 %)
aMissing variables (n = 2–5)
Table 2 Prevalence rates for all MINI diagnoses
Diagnosis n (% of total sample)
Depression
Current 77 (52 %)
Recurrent 53 (36 %)
Dysthymia 14 (10 %)
Suicidality
Low 57 (39 %)
Moderate 14 (10 %)
High 5 (3 %)
Hypomania
Current 6 (4 %)
Past 24 (16 %)
Mania
Current 4 (3 %)
Past 18 (12 %)
Panic Disorder
Current 26 (18 %)
Lifetime 37 (25 %)
Agoraphobia 70 (48 %)
Social Phobia
Generalized 33 (22 %)
Non-generalized 16 (11 %)
Obsessive Compulsive Disorder 27 (18 %)
Post-Traumatic Stress Disorder 18 (21 %)
Alcohol Dependence 27 (18 %)
Substance Dependence 11 (7 %)
Mood disorder with Psychotic features
Current 7 (5 %)
Lifetime 10 (7 %)
Psychosis
Current 2 (1 %)
Lifetime 5 (3 %)
Bulimia 5 (3 %)
Generalized Anxiety Disorder 100 (66 %)
Antisocial Personality Disorder 6 (4 %)
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breakdown of the types and severity of childhood trauma
are presented in Table 4.
Discussion
To our knowledge, this is the first study to systematically
assess the diagnostic case-mix of an Improving Access to
Psychological Therapies (IAPT) service. Much of the previ-
ous data on IAPT services comes from IAPT reports or
only includes data collected as part of standard clinical
practice. The PROMPT protocol provides an opportunity
for the systematic collection of additional and detailed clin-
ical, psychosocial and biological data. Here, we have pre-
sented the progress of the study in its first year and a
description of the sample. Our early findings have
highlighted two key points: the complexities present within
an ostensibly straightforward population with common
mental disorders treated at the primary care/secondary care
interface, and also the challenges of recruiting patients from
routine clinical care into a naturalistic study such as this.
Our initial data show the degree of psychiatric comor-
bidity present in patients seen within the Southwark
IAPT service. Based on the diagnoses obtained using the
MINI, we have shown that comorbidity is the rule: 14 %
of our sample met criteria for two current diagnoses
and the majority (58 %) had three or more current diag-
noses. This degree of comorbidity is in keeping with the
figures reported by Southwark Psychological Therapies
Service where 53 % of all patients in the service were
found to meet criteria for two or more diagnoses on the
Psychiatric Diagnostic Screening Questionnaire (PDSQ)
[16]. Similarly, the proportion of caseness identified
using the PHQ-9 and GAD-7 in our sample are also
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Fig. 2 Prevalence rates for current MINI diagnoses
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Fig. 3 Prevalence rates for multiple MINI diagnoses
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consistent with those reported by the service (72 and
78 % versus 71 and 74 %, respectively). Other national
reports of caseness within IAPT services as identified
using the PHQ-9 and GAD-7 are also similar at 84 and
79 % in one study [17], and 70 and 68 % in another [18].
Taken together, these data indicate that our sample is
clinically representative of that seen by the IAPT service
as a whole both locally and nationally. We also found high
rates of likely traits of personality disorder, with structured
interviewing suggesting the definitive presence of border-
line personality disorder in 16 % and more general screen-
ing suggesting around two-thirds had some features of
personality disorder. It has recently been demonstrated
that the presence of co-morbid personality difficulties ad-
versely affects treatment outcome among individuals
attending IAPT treatment [19]. In addition to the level of
comorbidity, for over a third of our sample, this was not
the first presentation to the Southwark IAPT service.
Our results also indicate a high level of potential bipolar-
ity in this population. As well as 28 % with a lifetime history
of mania or hypomania, we found that 61 % of participants
scored above the cut-off on the HCL-16, suggesting a large
proportion of the patients with depression seen within
the IAPT service fall within the “soft” bipolar spectrum
[20, 21]. This is in keeping with data from the large Bipolar
Disorder: Improving Diagnosis Guidance and Education
(BRIDGE) study where a prevalence rate of 58.7 % was
found using the longer 32 item hypomania checklist (HCL-
32) in a population of community and hospital patients
with depression [22]. Unrecognised bipolarity is thought to
be a significant factor contributing to treatment resistance
in depression [23], and is therefore of great potential signifi-
cance as a possible predictor within the current study. Fur-
thermore, the management of bipolar spectrum disorders
is complex and differs from that of unipolar depression,
both in terms of pharmacological and psychological therapy
with particular uncertainty about the benefits or otherwise
of antidepressants [24]. Also, and of specific relevance for
IAPT services, there is less evidence from clinical trials for
the use of psychological therapies such as CBT in bipolar
spectrum disorders, and results have been inconclusive
[25–27]. The focus of such therapies may also need to be
different in the presence of a bipolar diathesis. Recurrence
rates are also higher: approximately 60 % of patients with
bipolar disorder relapse within 2 years of remission from a
major depressive or manic episode [28].
Perhaps in keeping with the diagnostic complexities,
our initial data also provides evidence for a high preva-
lence of childhood trauma in this population. This is not
surprising as the association between childhood trauma
and increased risk for adult psychopathology (especially
depression) is well documented [29–31]. Moreover, a
history of childhood trauma has also been shown to be
associated with other disorders including bipolar dis-
order and personality disorder [32–34], both of which
are prevalent in our sample. In relation to treatment
outcomes, a recent meta-analysis in depression revealed
that maltreated individuals were twice as likely to have a
poorer prognosis when compared to those without any
Table 3 Breakdown of PHQ-9 and GAD-7 scores
n (% of total sample)
PHQ-9a
Minimal (0–4) 17 (12 %)
Mild (5–9) 23 (16 %)
Moderate (10–14) 40 (28 %)
Severe (≥15) 64 (44 %)
GAD-7a
Minimal (0–4) 16 (11 %)
Mild (5–9) 30 (21 %)
Moderate (10–14) 46 (32 %)
Severe (≥15) 52 (36 %)
aMissing variables (n = 3)
Table 4 Prevalence rates of childhood trauma
Trauma Type n (% of total sample)
Emotional Abusea
None 74 (52 %)
Low 26 (19 %)
Moderate 11 (8 %)
Severe 30 (21 %)
Physical Abusea
None 114 (80 %)
Low 6 (4 %)
Moderate 10 (7 %)
Severe 12 (9 %)
Sexual Abusea
None 92 (65 %)
Low 20 (14 %)
Moderate 18 (13 %)
Severe 11 (8 %)
Emotional Neglecta
None 61 (43 %)
Low 37 (26 %)
Moderate 17 (12 %)
Severe 28 (19 %)
Physical Neglecta
None 91 (64 %)
Low 18 (13 %)
Moderate 15 (10 %)
Severe 19 (13 %)
aMissing variables (n = 4–6)
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history of childhood trauma [35]. Indeed, this high
prevalence of childhood trauma in combination with the
diagnostic complexities may contribute to the low recov-
ery rates seen in this population. Furthermore, we also
demonstrate a substantial prevalence of alcohol and drug
dependence in our sample (18 and 7 %, respectively)
both of which may also have serious implications for
treatment outcomes.
Taken together, our early findings suggest that patients
seen by Southwark IAPT have complex psychopathologies.
Given that IAPT services were originally targeted for indi-
viduals with mild to moderate depression and anxiety, and
are often seen as an early intervention/primary care ser-
vice, this high level of multi-morbidity may pose significant
implications for treatment provision and outcomes. The
presence of psychiatric comorbidities may affect treatment
outcomes in a number of ways such as increased rates of
treatment drop out, and are a recognized factor conferring
a worsened outcome to treatment in general. It may also
lead to difficulties in establishing effective therapeutic rela-
tionships and therefore require additional training for
IAPT staff. There is existing evidence to suggest that pa-
tients with complex psychopathologies might benefit from
alternative therapies or integrative therapies. Integrative
therapies can allow clinicians to combine interventions so
that they are tailored for the presence of comorbidity. This
has been suggested to be useful for the treatment of co-
morbid personality disorder [36, 37] and for generalized
anxiety disorder [38]. However, this may require additional
training for IAPT staff and have associated cost implica-
tions. Our findings suggest that large numbers of patients
presenting to these services may have significant needs
over and above those likely to be met by the relatively brief
interventions that IAPT services are currently expected
and are able to provide.
Collecting data from participants in a naturalistic setting,
whilst providing ecologically valid data, is not without its
limitations. This is a naturalistic, observational project and
therefore our original sample size estimates were based on
patient throughput and human resources. We had esti-
mated to recruit up to 600 patients in the first year of the
project [6]. However, our results from the first year of re-
cruitment have highlighted appreciable difficulties in the
process of recruitment. The first main obstacle is that only
a minority of patients attending Southwark IAPT consent
to be contacted for any research purposes. A second major
obstacle has been that we were unable to establish contact
with 50 % of the identified potential participants. Addition-
ally, 63 % of the participants recruited in to the study were
waiting to receive high intensity treatments. This is a
higher proportion than what might be expected of an IAPT
service where usually low intensity treatments are more
frequent. An evaluation of five primary care trusts reported
that 57.3 % of patient received low intensity treatments
and 26.2 % received high intensity [18]. One explanation
for this difference is that high intensity treatments involve
a substantial waiting period whereas low intensity treat-
ments are started much more quickly. As such, there is a
smaller window of opportunity to contact patients and in-
volve them in research prior to starting therapy. Thus, an
important outcome from the study to date has been identi-
fying these areas as potential factors to be considered both
in the ongoing implementation of the current study, but
also in the design and recruitment processes of any similar
studies in future. This may require organisational changes
in order to better embed research in to clinical practice.
There are some limitations to this study. Firstly, the
PROMPT project focusses on one urban London IAPT ser-
vice (Southwark). As such; the degree to which the figures
presented may generalize to other IAPT services, including
those in more rural areas, needs further exploration. Sec-
ondly, the participants are recruited via the consent for
contact initiative and it is possible that those who agree to
research contact are not representative of all patients re-
ferred to and seen in Southwark IAPT. This would be of
particular concern if increased likelihood of participation in
research was perhaps related to comorbidity. However, epi-
demiological evidence suggests that more severe psycho-
pathology is associated with a reduced likelihood of
participation in research [39] and hence it is probable that
the patients who declined to participate had more, not less,
psychopathology. Furthermore, it is unlikely that our sam-
ple is clinically more severe as comparisons with figures re-
ported by Southwark Psychological Therapies Service
confirm that our sample is clinically and demographically
similar to the population of the service [16]. In terms of
study methodology, the main limitations are those of the
underlying tools used. Thus, for example, the estimates of
bipolarity are limited by the uncertain nature of a retro-
spective assessment of hypomania, and by the sensitivity/
specificity of the HCL questionnaire. The estimates of per-
sonality disorder traits are similarly limited by the self-
report nature of the tools used, and the likely overestimate
of such traits when assessed during a depressive episode.
Nevertheless, we believe that the findings are valid within
these constraints, and within the limits of the information
that can realistically be obtained from a sample of patients
such as this.
Conclusions
In conclusion, the results to date from the PROMPT
project confirm the feasibility of such a study, whilst em-
phasizing the very significant challenges that are faced
when recruiting in this population. Moreover, the results
have revealed the complex nature of the patients seen
within an urban IAPT service, with high rates of psychi-
atric comorbidity, bipolarity, childhood trauma and traits
of personality disorder.
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